{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T15:47:05Z","timestamp":1792079225741,"version":"4.4.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100013041","name":"Vice-Chancellor for Research, Shiraz University of Medical Sciences","doi-asserted-by":"publisher","award":["27880"],"award-info":[{"award-number":["27880"]}],"id":[{"id":"10.13039\/501100013041","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Appl Biochem Biotechnol"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1007\/s12010-026-05900-w","type":"journal-article","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T13:59:39Z","timestamp":1788271179000},"page":"9293-9311","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Non-Covalent Active Mixing as a Viable Alternative to Covalent Conjugation for the Intracellular Delivery of Biologics: The Case of Glucarpidase"],"prefix":"10.1007","volume":"198","author":[{"given":"Yasaman","family":"Behzadipour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9071-9569","authenticated-orcid":false,"given":"Shiva","family":"Hemmati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,1]]},"reference":[{"key":"5900_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115292","volume":"166","author":"F Moradbeygi","year":"2023","unstructured":"Moradbeygi, F., Ghasemi, Y., Farmani, A. R., & Hemmati, S. (2023). Glucarpidase (carboxypeptidase G2): Biotechnological production, clinical application as a methotrexate antidote, and placement in targeted cancer therapy. Biomedicine & Pharmacotherapy, 166, Article 115292. https:\/\/doi.org\/10.1016\/j.biopha.2023.115292","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"5900_CR2","doi-asserted-by":"publisher","unstructured":"Kala, J., & Howard, S. C. (2025). High-dose methotrexate nephrotoxicity. American Journal of Nephrology. Retrieved from https:\/\/karger.com\/ajn\/article-abstract\/doi\/https:\/\/doi.org\/10.1159\/000549144\/937918","DOI":"10.1159\/000549144\/937918"},{"key":"5900_CR3","doi-asserted-by":"publisher","DOI":"10.2147\/TCRM.S30135","author":"J Green","year":"2012","unstructured":"Green, J. (2012). Glucarpidase to combat toxic levels of methotrexate in patients. Therapeutics and Clinical Risk Management. https:\/\/doi.org\/10.2147\/TCRM.S30135","journal-title":"Therapeutics and Clinical Risk Management"},{"key":"5900_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110009","volume":"125","author":"SS Bashraheel","year":"2020","unstructured":"Bashraheel, S. S., Domling, A., & Goda, S. K. (2020). Update on targeted cancer therapies, single or in combination, and their fine tuning for precision medicine. Biomedicine & Pharmacotherapy, 125, Article 110009. https:\/\/doi.org\/10.1016\/j.biopha.2020.110009","journal-title":"Biomedicine & Pharmacotherapy"},{"issue":"18","key":"5900_CR5","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1002\/cbic.201800186","volume":"19","author":"D Jeyaharan","year":"2018","unstructured":"Jeyaharan, D., Brackstone, C., Schouten, J., Davis, P., & Dixon, A. M. (2018). Characterisation of the carboxypeptidase G2 catalytic site and design of new inhibitors for cancer therapy. Chembiochem, 19(18), 1959\u20131968. https:\/\/doi.org\/10.1002\/cbic.201800186","journal-title":"Chembiochem"},{"issue":"12","key":"5900_CR6","doi-asserted-by":"publisher","DOI":"10.1002\/adbi.202500326","volume":"9","author":"JC Kalaw San Pascual","year":"2025","unstructured":"Kalaw San Pascual, J. C., & Kangsamaksin, T. (2025). Biologics, biosimilars, and biobetters: Therapeutic innovations reshaping modern medicine. Advanced Biology, 9(12), Article e00326. https:\/\/doi.org\/10.1002\/adbi.202500326","journal-title":"Advanced Biology"},{"issue":"2","key":"5900_CR7","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/s41589-021-00932-1","volume":"18","author":"TJ Gardner","year":"2022","unstructured":"Gardner, T. J., Lee, J. P., Bourne, C. M., Wijewarnasuriya, D., Kinarivala, N., Kurtz, K. G., Corless, B. C., Dacek, M. M., Chang, A. Y., Nguyen, K. M., Brentjens, R. J., Tan, D. S., Scheinberg, D. A., & Mo, G. (2022). Engineering CAR-T cells to activate small-molecule drugs in situ. Nature Chemical Biology, 18(2), 216\u2013225. https:\/\/doi.org\/10.1038\/s41589-021-00932-1","journal-title":"Nature Chemical Biology"},{"key":"5900_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.108725","volume":"112","author":"AD Al-Qahtani","year":"2019","unstructured":"Al-Qahtani, A. D., Bashraheel, S. S., Rashidi, F. B., O\u2019Connor, C. D., Romero, A. R., Domling, A., & Goda, S. K. (2019). Production of \u201cbiobetter\u201d variants of glucarpidase with enhanced enzyme activity. Biomedicine & Pharmacotherapy, 112, Article 108725. https:\/\/doi.org\/10.1016\/j.biopha.2019.108725","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"5900_CR9","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.ejps.2018.10.014","volume":"127","author":"AD AlQahtani","year":"2019","unstructured":"AlQahtani, A. D., Al-Mansoori, L., Bashraheel, S. S., Rashidi, F. B., Al-Yafei, A., Elsinga, P., & Goda, S. K. (2019). Production of biobetter glucarpidase variants to improve drug detoxification and antibody directed enzyme prodrug therapy for cancer treatment. European Journal of Pharmaceutical Sciences, 127, 79\u201391. https:\/\/doi.org\/10.1016\/j.ejps.2018.10.014","journal-title":"European Journal of Pharmaceutical Sciences"},{"key":"5900_CR10","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1007\/s12033-021-00370-3","volume":"63","author":"I Sadeghian","year":"2021","unstructured":"Sadeghian, I., & Hemmati, S. (2021). Characterization of a stable form of carboxypeptidase G2 (glucarpidase), a potential biobetter variant, from Acinetobacter sp. 263903-1. Molecular Biotechnology, 63, 1155\u20131168. https:\/\/doi.org\/10.1007\/s12033-021-00370-3","journal-title":"Molecular Biotechnology"},{"key":"5900_CR11","doi-asserted-by":"publisher","unstructured":"Porosk, L., & Langel, \u00dc. (2025). Addressing the Blood-Brain Barrier: Overcoming Glioblastoma Drug Delivery. In \u00dc. Langel (Ed.), Cancer-Targeted Drug Delivery (pp. 83\u2013104). Springer US. https:\/\/doi.org\/10.1007\/978-1-0716-4374-7_5","DOI":"10.1007\/978-1-0716-4374-7_5"},{"issue":"11","key":"5900_CR12","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1080\/17425255.2023.2272593","volume":"19","author":"K Kielbowski","year":"2023","unstructured":"Kielbowski, K., Rosik, J., Bakinowska, E., Gromowska, E., Ustianowski, \u0141., Szostak, B., & Pawlik, A. (2023). The use of glucarpidase as a rescue therapy for high dose methotrexate toxicity \u2013 a review of pharmacological and clinical data. Expert Opinion on Drug Metabolism & Toxicology, 19(11), 741\u2013750. https:\/\/doi.org\/10.1080\/17425255.2023.2272593","journal-title":"Expert Opinion on Drug Metabolism & Toxicology"},{"key":"5900_CR13","doi-asserted-by":"publisher","first-page":"153303382110573","DOI":"10.1177\/15330338211057371","volume":"20","author":"L Al-mansoori","year":"2021","unstructured":"Al-mansoori, L., Qahtani, A., Elsinga, A. D., P., & Goda, S. K. (2021). Production of long-acting CNGRC\u2013CPG2 fusion proteins: new derivatives to overcome drug immunogenicity of ligand-directed enzyme prodrug therapy for targeted cancer treatment. Technology in Cancer Research & Treatment, 20, 15330338211057371. https:\/\/doi.org\/10.1177\/15330338211057371","journal-title":"Technology in Cancer Research & Treatment"},{"issue":"1","key":"5900_CR14","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s12885-021-09164-x","volume":"22","author":"LR Schaff","year":"2022","unstructured":"Schaff, L. R., Lobbous, M., Carlow, D., Schofield, R., Gavrilovic, I. T., Miller, A. M., & Grommes, C. (2022). Routine use of low-dose glucarpidase following high-dose methotrexate in adult patients with CNS lymphoma: An open-label, multi-center phase I study. Bmc Cancer, 22(1), 60. https:\/\/doi.org\/10.1186\/s12885-021-09164-x","journal-title":"Bmc Cancer"},{"issue":"3","key":"5900_CR15","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1097\/sla.0000000000004102","volume":"272","author":"EM Bulger","year":"2020","unstructured":"Bulger, E. M., May, A. K., Robinson, B. R., Evans, D. C., Henry, S., Green, J. M., & Martin, N. D. (2020). A novel immune modulator for patients with necrotizing soft tissue infections (NSTI): Results of a multicenter, phase 3 randomized controlled trial of reltecimod (AB 103). Annals of Surgery, 272(3), 469\u2013478. https:\/\/doi.org\/10.1097\/sla.0000000000004102","journal-title":"Annals of Surgery"},{"issue":"3","key":"5900_CR16","doi-asserted-by":"publisher","first-page":"S133","DOI":"10.1016\/j.gim.2022.01.249","volume":"24","author":"C Campbell","year":"2022","unstructured":"Campbell, C., Mathews, K., van de Rijn, M., Palatinsky, E., Ni, X., Sha, N., & O\u2019Rourke, E. (2022). eP213: Phase 2 multiple ascending-dose study of SRP-5051 PPMO in patients with DMD amenable to exon 51 skipping: Part A results. Genetics in Medicine, 24(3), S133. https:\/\/doi.org\/10.1016\/j.gim.2022.01.249","journal-title":"Genetics in Medicine"},{"issue":"5","key":"5900_CR17","doi-asserted-by":"publisher","first-page":"617","DOI":"10.3390\/pharmaceutics16050617","volume":"16","author":"J Nebogatova","year":"2024","unstructured":"Nebogatova, J., Porosk, L., H\u00e4rk, H. H., & Kurrikoff, K. (2024). Enhancing cellular uptake of native proteins through bio-orthogonal conjugation with chemically synthesized cell-penetrating peptides. Pharmaceutics, 16(5), 617. https:\/\/doi.org\/10.3390\/pharmaceutics16050617","journal-title":"Pharmaceutics"},{"issue":"5","key":"5900_CR18","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1097\/MAO.0000000000002229","volume":"40","author":"H Staecker","year":"2019","unstructured":"Staecker, H., Jokovic, G., Karpishchenko, S., Kienle-Gogolok, A., Krzyzaniak, A., & Lin, C. D.\u2026 Meyer, T. (2019). Efficacy and safety of AM-111 in the treatment of acute unilateral sudden deafness\u2014a double-blind, randomized, placebo-controlled phase 3 study. Otology & Neurotology, 40(5), 584\u2013594. https:\/\/doi.org\/10.1097\/MAO.0000000000002229","journal-title":"Otology & Neurotology"},{"key":"5900_CR19","doi-asserted-by":"publisher","first-page":"116910","DOI":"10.1016\/j.biopha.2024.116910","volume":"176","author":"Y Behzadipour","year":"2024","unstructured":"Behzadipour, Y., & Hemmati, S. (2024). Covalent conjugation and non-covalent complexation strategies for intracellular delivery of proteins using cell-penetrating peptides. Biomedicine & Pharmacotherapy, 176, 116910. https:\/\/doi.org\/10.1016\/j.biopha.2024.116910","journal-title":"Biomedicine & Pharmacotherapy"},{"issue":"1","key":"5900_CR20","first-page":"1","volume":"9","author":"X Chang","year":"2018","unstructured":"Chang, X., & Hou, Y. (2018). Expression of RecA and cell-penetrating peptide (CPP) fusion protein in bacteria and in mammalian cells. International Journal of Biochemistry and Molecular Biology, 9(1), 1. https:\/\/pubmed.ncbi.nlm.nih.gov\/29531845\/","journal-title":"International Journal of Biochemistry and Molecular Biology"},{"key":"5900_CR21","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.taap.2018.03.023","volume":"346","author":"I Sadeghian","year":"2018","unstructured":"Sadeghian, I., Khalvati, B., Ghasemi, Y., & Hemmati, S. (2018). TAT-mediated intracellular delivery of carboxypeptidase G2 protects against methotrexate-induced cell death in HepG2 cells. Toxicology and applied pharmacology, 346, 9\u201318. https:\/\/doi.org\/10.1016\/j.taap.2018.03.023","journal-title":"Toxicology and applied pharmacology"},{"key":"5900_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2025.117241","volume":"285","author":"Y Wang","year":"2025","unstructured":"Wang, Y., Yang, F., Wang, B., Xie, L., & Chen, W. (2025). New FDA drug approvals for 2024: Synthesis and clinical application. European Journal of Medicinal Chemistry, 285, Article 117241. https:\/\/doi.org\/10.1016\/j.ejmech.2025.117241","journal-title":"European Journal of Medicinal Chemistry"},{"issue":"3","key":"5900_CR23","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1021\/bc5005763","volume":"26","author":"M Kristensen","year":"2015","unstructured":"Kristensen, M., de Groot, A. M., Berthelsen, J., Franzyk, H., Sijts, A., & Nielsen, H. M. (2015). Conjugation of cell-penetrating peptides to parathyroid hormone affects its structure, potency, and transepithelial permeation. Bioconjugate Chemistry, 26(3), 477\u2013488. https:\/\/doi.org\/10.1021\/bc5005763","journal-title":"Bioconjugate Chemistry"},{"key":"5900_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.1056467","volume":"13","author":"L Porosk","year":"2022","unstructured":"Porosk, L., & Langel, \u00dc. (2022). Approaches for evaluation of novel CPP-based cargo delivery systems. Frontiers in Pharmacology, 13, Article 1056467. https:\/\/doi.org\/10.3389\/fphar.2022.1056467","journal-title":"Frontiers in Pharmacology"},{"issue":"3","key":"5900_CR25","doi-asserted-by":"publisher","first-page":"469","DOI":"10.3390\/ph16030469","volume":"16","author":"J Moreno","year":"2023","unstructured":"Moreno, J., Zoghebi, K., Salehi, D., Kim, L., Shoushtari, S. K., Tiwari, R. K., & Parang, K. (2023). Amphiphilic cell-penetrating peptides containing arginine and hydrophobic residues as protein delivery agents. Pharmaceuticals, 16(3), 469. https:\/\/doi.org\/10.3390\/ph16030469","journal-title":"Pharmaceuticals"},{"key":"5900_CR26","doi-asserted-by":"publisher","DOI":"10.2147\/ijn.s428684","author":"W Hu","year":"2024","unstructured":"Hu, W., Cai, W., Wu, Y., Ren, C., Yu, D., Li, T., Shen, T., Xu, D., & Yu, J. (2024). Topical application of cell-penetrating peptide modified anti-VEGF drug alleviated choroidal neovascularization in mice. International Journal of Nanomedicine. https:\/\/doi.org\/10.2147\/ijn.s428684","journal-title":"International Journal of Nanomedicine"},{"key":"5900_CR27","doi-asserted-by":"publisher","unstructured":"Krishnamurthy, S., Wohlford-Lenane, C., Kandimalla, S., Sartre, G., Meyerholz, D. K., Th\u00e9berge, V., Hall\u00e9e, S., Duperr\u00e9, A.-M., Del\u2019Guidice, T., Barbeau, X., Guay, D., McCray, P. B., Jr., & Lepetit-Stoffaes, J.-P. (2019). Engineered amphiphilic peptides enable delivery of proteins and CRISPR-associated nucleases to airway epithelia. Nature Communications, 10(1), Article 4906. https:\/\/doi.org\/10.1038\/s41467-019-12922-y","DOI":"10.1038\/s41467-019-12922-y"},{"issue":"4","key":"5900_CR28","first-page":"1","volume":"28","author":"N Salame","year":"2023","unstructured":"Salame, N., Eber, A. E., & Dover, J. (2023). DaxibotulinumtoxinA-lanm (Daxxify\u2122): A Comprehensive Overview. Skin Therapy Letter, 28(4), 1\u20133.","journal-title":"Skin Therapy Letter"},{"issue":"23","key":"5900_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/molecules24234318","volume":"24","author":"Y Behzadipour","year":"2019","unstructured":"Behzadipour, Y., & Hemmati, S. (2019). Considerations on the rational design of covalently conjugated cell-penetrating peptides (CPPs) for intracellular delivery of proteins: A guide to CPP selection using glucarpidase as the model cargo molecule. Molecules, 24(23), Article 4318. https:\/\/doi.org\/10.3390\/molecules24234318","journal-title":"Molecules"},{"issue":"W1","key":"5900_CR30","doi-asserted-by":"publisher","first-page":"W449","DOI":"10.1093\/nar\/gkw329","volume":"44","author":"A Lamiable","year":"2016","unstructured":"Lamiable, A., Th\u00e9venet, P., Rey, J., Vavrusa, M., Derreumaux, P., & Tuff\u00e9ry, P. (2016). PEP-FOLD3: Faster de novo structure prediction for linear peptides in solution and in complex. Nucleic Acids Research, 44(W1), W449\u2013W454. https:\/\/doi.org\/10.1093\/nar\/gkw329","journal-title":"Nucleic Acids Research"},{"issue":"2","key":"5900_CR31","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/nprot.2016.169","volume":"12","author":"D Kozakov","year":"2017","unstructured":"Kozakov, D., Hall, D. R., Xia, B., Porter, K. A., Padhorny, D., Yueh, C., Beglov, D., & Vajda, S. (2017). The ClusPro web server for protein\u2013protein docking. Nature Protocols, 12(2), 255\u2013278. https:\/\/doi.org\/10.1038\/nprot.2016.169","journal-title":"Nature Protocols"},{"issue":"1","key":"5900_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10989-021-10357-y","volume":"28","author":"Y Behzadipour","year":"2022","unstructured":"Behzadipour, Y., & Hemmati, S. (2022). Viral prefusion targeting using entry inhibitor peptides: the case of SARS-CoV-2 and influenza a virus. International Journal of Peptide Research and Therapeutics, 28(1), 1\u201319. https:\/\/doi.org\/10.1007\/s10989-021-10357-y","journal-title":"International Journal of Peptide Research and Therapeutics"},{"issue":"W1","key":"5900_CR33","doi-asserted-by":"publisher","first-page":"W463","DOI":"10.1093\/nar\/gkaf361","volume":"53","author":"P Schake","year":"2025","unstructured":"Schake, P., Bolz, S. N., Linnemann, K., & Schroeder, M. (2025). PLIP 2025: Introducing protein\u2013protein interactions to the protein\u2013ligand interaction profiler. Nucleic acids research, 53(W1), W463\u2013W465. https:\/\/doi.org\/10.1093\/nar\/gkaf361","journal-title":"Nucleic acids research"},{"key":"5900_CR34","doi-asserted-by":"publisher","DOI":"10.1007\/s12033-025-01450-4","author":"F Moradbeygi","year":"2025","unstructured":"Moradbeygi, F., Ghoshoon, M. B., Sadeghian, I., Moradi, A., Ghasemi, Y., Morowvat, M. H., & Hemmati, S. (2025). Toward the development of a biosimilar variant of glucarpidase (Carboxypeptidase G2): secretory production, optimization, and immobilization. Molecular Biotechnology. https:\/\/doi.org\/10.1007\/s12033-025-01450-4","journal-title":"Molecular Biotechnology"},{"issue":"1","key":"5900_CR35","doi-asserted-by":"publisher","DOI":"10.1002\/btpr.3071","volume":"37","author":"Y Behzadipour","year":"2021","unstructured":"Behzadipour, Y., Sadeghian, I., Ghaffarian Bahraman, A., & Hemmati, S. (2021). Introducing a delivery system for melanogenesis inhibition in melanoma B16F10 cells mediated by the conjugation of tyrosine ammonia-lyase and a TAT\u2010penetrating peptide. Biotechnology Progress, 37(1), Article e3071. https:\/\/doi.org\/10.1002\/btpr.3071","journal-title":"Biotechnology Progress"},{"issue":"1\u20132","key":"5900_CR36","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","volume":"72","author":"MM Bradford","year":"1976","unstructured":"Bradford, M. M. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry, 72(1\u20132), 248\u2013254. https:\/\/doi.org\/10.1016\/0003-2697(76)90527-3","journal-title":"Analytical Biochemistry"},{"issue":"23","key":"5900_CR37","doi-asserted-by":"publisher","first-page":"7207","DOI":"10.1016\/S0021-9258(19)45873-0","volume":"246","author":"JL McCullough","year":"1971","unstructured":"McCullough, J. L., Chabner, B. A., & Bertino, J. R. (1971). Purification and properties of carboxypeptidase G1. Journal of Biological Chemistry, 246(23), 7207\u20137213.","journal-title":"Journal of Biological Chemistry"},{"issue":"2","key":"5900_CR38","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.5920\/bjpharm.1373","volume":"8","author":"M Alkotaji","year":"2023","unstructured":"Alkotaji, M. (2023). Cell penetrating peptides (CPPs): A new era for localised drug delivery. British Journal of Pharmacy, 8(2), S1\u2013S2. https:\/\/doi.org\/10.5920\/bjpharm.1373","journal-title":"British Journal of Pharmacy"},{"key":"5900_CR39","doi-asserted-by":"publisher","DOI":"10.1007\/s13346-025-01842-8","author":"SE Schmidt","year":"2025","unstructured":"Schmidt, S. E., Joensen, G., Sandbjerg, C., Thaysen, M., Gammelgaard, B., Schindowski, K., & Kristensen, M. (2025). The PSD-95 inhibitor NA-1 is delivered to the brain upon nasal administration with uptake into the olfactory bulb improved by co-administration with the cell-penetrating peptides lowPro and Tat. Drug Delivery and Translational Research. https:\/\/doi.org\/10.1007\/s13346-025-01842-8","journal-title":"Drug Delivery and Translational Research"},{"issue":"1","key":"5900_CR40","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1038\/s41388-018-0421-y","volume":"38","author":"E Wang","year":"2019","unstructured":"Wang, E., Sorolla, A., Cunningham, P. T., Bogdawa, H. M., Beck, S., Golden, E., Dewhurst, R. E., Florez, L., Cruickshank, M. N., Hopkins, R. M., Kim, J., Woo, A. J., Watt, P. M., Blancafort, P., & Hoffmann, K. (2019). Tumor penetrating peptides inhibiting MYC as a potent targeted therapeutic strategy for triple-negative breast cancers. Oncogene, 38(1), 140\u2013150. https:\/\/doi.org\/10.1038\/s41388-018-0421-y","journal-title":"Oncogene"},{"issue":"2","key":"5900_CR41","doi-asserted-by":"publisher","first-page":"184","DOI":"10.3390\/ph6020184","volume":"6","author":"A-A Keller","year":"2013","unstructured":"Keller, A.-A., Mussbach, F., Breitling, R., Hemmerich, P., Schaefer, B., Lorkowski, S., & Reissmann, S. (2013). Relationships between cargo, cell penetrating peptides and cell type for uptake of non-covalent complexes into live cells. Pharmaceuticals, 6(2), 184\u2013203. https:\/\/doi.org\/10.3390\/ph6020184","journal-title":"Pharmaceuticals"},{"issue":"5","key":"5900_CR42","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1002\/psc.2396","volume":"18","author":"J M\u00fcller","year":"2012","unstructured":"M\u00fcller, J., Triebus, J., Kretzschmar, I., Volkmer, R., & Boisguerin, P. (2012). The agony of choice: How to find a suitable CPP for cargo delivery. Journal of Peptide Science, 18(5), 293\u2013301. https:\/\/doi.org\/10.1002\/psc.2396","journal-title":"Journal of Peptide Science"},{"issue":"3","key":"5900_CR43","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/s0969-2126(97)00191-3","volume":"5","author":"S Rowsell","year":"1997","unstructured":"Rowsell, S., Pauptit, R. A., Tucker, A. D., Melton, R. G., Blow, D. M., & Brick, P. (1997). Crystal structure of carboxypeptidase G2, a bacterial enzyme with applications in cancer therapy. Structure, 5(3), 337\u2013347. https:\/\/doi.org\/10.1016\/s0969-2126(97)00191-3","journal-title":"Structure"},{"issue":"1","key":"5900_CR44","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1021\/acs.molpharmaceut.5b00598","volume":"13","author":"H Margus","year":"2016","unstructured":"Margus, H., Arukuusk, P., Langel, \u00dc., & Pooga, M. (2016). Characteristics of cell-penetrating peptide\/nucleic acid nanoparticles. Molecular Pharmaceutics, 13(1), 172\u2013179. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.5b00598","journal-title":"Molecular Pharmaceutics"},{"key":"5900_CR45","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.00697","volume":"11","author":"J Xie","year":"2020","unstructured":"Xie, J., Bi, Y., Zhang, H., Dong, S., Teng, L., Lee, R. J., & Yang, Z. (2020). Cell-penetrating peptides in diagnosis and treatment of human diseases: From preclinical research to clinical application. Frontiers in Pharmacology, 11, Article 697. https:\/\/doi.org\/10.3389\/fphar.2020.00697","journal-title":"Frontiers in Pharmacology"},{"issue":"4","key":"5900_CR46","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s12551-016-0218-6","volume":"8","author":"J Stetefeld","year":"2016","unstructured":"Stetefeld, J., McKenna, S. A., & Patel, T. R. (2016). Dynamic light scattering: a practical guide and applications in biomedical sciences. Biophysical reviews, 8(4), 409\u2013427. https:\/\/doi.org\/10.1007\/s12551-016-0218-6","journal-title":"Biophysical reviews"},{"key":"5900_CR47","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.jconrel.2016.06.017","volume":"235","author":"S Bhattacharjee","year":"2016","unstructured":"Bhattacharjee, S. (2016). DLS and zeta potential\u2013what they are and what they are not? Journal of controlled release, 235, 337\u2013351. https:\/\/doi.org\/10.1016\/j.jconrel.2016.06.017","journal-title":"Journal of controlled release"},{"issue":"6","key":"5900_CR48","doi-asserted-by":"publisher","DOI":"10.1111\/boc.70012","volume":"117","author":"M Okafor","year":"2025","unstructured":"Okafor, M., Schmitt, D., Ory, S., Gasman, S., Hureau, C., Faller, P., & Vitale, N. (2025). The different cellular entry routes for drug delivery using cell penetrating peptides. Biology of the Cell, 117(6), Article e70012. https:\/\/doi.org\/10.1111\/boc.70012","journal-title":"Biology of the Cell"},{"issue":"1","key":"5900_CR49","doi-asserted-by":"publisher","first-page":"101","DOI":"10.3762\/bjnano.11.10","volume":"11","author":"I Ruseska","year":"2020","unstructured":"Ruseska, I., & Zimmer, A. (2020). Internalization mechanisms of cell-penetrating peptides. Beilstein journal of nanotechnology, 11(1), 101\u2013123. https:\/\/doi.org\/10.3762\/bjnano.11.10","journal-title":"Beilstein journal of nanotechnology"},{"issue":"2","key":"5900_CR50","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1021\/acsnano.5c18112","volume":"20","author":"G Chahal","year":"2026","unstructured":"Chahal, G., Helbig, K., Parton, R., & Monson, E. (2026). The biology of endosomal escape: strategies for enhanced delivery of therapeutics. Acs Nano, 20(2), 1789\u20131813. https:\/\/doi.org\/10.1021\/acsnano.5c18112","journal-title":"Acs Nano"},{"issue":"6","key":"5900_CR51","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1111\/tra.12272","volume":"16","author":"JA Daniel","year":"2015","unstructured":"Daniel, J. A., Chau, N., Abdel-Hamid, M. K., Hu, L., Von Kleist, L., Whiting, A., & Robinson, P. J. (2015). Phenothiazine\u2010derived antipsychotic drugs inhibit dynamin and clathrin\u2010mediated endocytosis. Traffic (Copenhagen, Denmark), 16(6), 635\u2013654. https:\/\/doi.org\/10.1111\/tra.12272","journal-title":"Traffic (Copenhagen, Denmark)"},{"issue":"18","key":"5900_CR52","doi-asserted-by":"publisher","first-page":"3640","DOI":"10.1111\/bph.14429","volume":"175","author":"H Lin","year":"2018","unstructured":"Lin, H., Singla, B., Ghoshal, P., Faulkner, J. L., Cherian-Shaw, M., & O\u2019Connor, P. M.\u2026 Cs\u00e1nyi, G. (2018). Identification of novel macropinocytosis inhibitors using a rational screen of food and drug administration\u2010approved drugs. British Journal of Pharmacology, 175(18), 3640\u20133655. https:\/\/doi.org\/10.1111\/bph.14429","journal-title":"British Journal of Pharmacology"},{"issue":"10","key":"5900_CR53","doi-asserted-by":"publisher","DOI":"10.1002\/mabi.202200167","volume":"22","author":"F Hausig-Punke","year":"2022","unstructured":"Hausig-Punke, F., Richter, F., Hoernke, M., Brendel, J. C., & Traeger, A. (2022). Tracking the endosomal escape: A closer look at calcein and related reporters. Macromolecular Bioscience, 22(10), Article 2200167. https:\/\/doi.org\/10.1002\/mabi.202200167","journal-title":"Macromolecular Bioscience"},{"issue":"48","key":"5900_CR54","doi-asserted-by":"publisher","first-page":"47461","DOI":"10.1021\/acsomega.4c05808","volume":"9","author":"M Uz","year":"2024","unstructured":"Uz, M., Bulmus, V., & Alsoy Altinkaya, S. (2024). Comparison of cell-penetrating and fusogenic TAT-HA2 peptide performance in peptideplex, multicomponent, and conjugate siRNA delivery systems. ACS Omega, 9(48), 47461\u201347474. https:\/\/doi.org\/10.1021\/acsomega.4c05808","journal-title":"ACS Omega"},{"issue":"38","key":"5900_CR55","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202304692","volume":"62","author":"Y Zhao","year":"2023","unstructured":"Zhao, Y., Jiang, H., Yu, J., Wang, L., & Du, J. (2023). Engineered histidine-rich peptides enhance endosomal escape for antibody\u2010targeted intracellular delivery of functional proteins. Angewandte Chemie International Edition, 62(38), Article e202304692. https:\/\/doi.org\/10.1002\/anie.202304692","journal-title":"Angewandte Chemie International Edition"},{"issue":"8","key":"5900_CR56","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9081033","volume":"9","author":"S Schoch","year":"2021","unstructured":"Schoch, S., Sen, V., Brenner, W., Hartwig, A., & K\u00f6berle, B. (2021). In vitro nephrotoxicity studies of established and experimental platinum-based compounds. Biomedicines, 9(8), Article 1033. https:\/\/doi.org\/10.3390\/biomedicines9081033","journal-title":"Biomedicines"},{"issue":"8","key":"5900_CR57","doi-asserted-by":"publisher","first-page":"2987","DOI":"10.1073\/pnas.1820161116","volume":"116","author":"LV Albrecht","year":"2019","unstructured":"Albrecht, L. V., Bui, M. H., & De Robertis, E. M. (2019). Canonical Wnt is inhibited by targeting one-carbon metabolism through methotrexate or methionine deprivation. Proceedings of the National Academy of Sciences of the United States of America, 116(8), 2987\u20132995. https:\/\/doi.org\/10.1073\/pnas.1820161116","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"5900_CR58","doi-asserted-by":"publisher","unstructured":"Capriles, C. A. A. (2023). CMC and GxP: Chemistry, manufacturing, and controls & good practice\u2019guidelines and regulations. Translational Sports Medicine (pp. 455\u2013456). Elsevier. https:\/\/doi.org\/10.1016\/B978-0-323-91259-4.00052-7","DOI":"10.1016\/B978-0-323-91259-4.00052-7"},{"key":"5900_CR59","doi-asserted-by":"publisher","unstructured":"Mohd Salleh, M. H., Peli, F., Ngalimat, A., M. S., & Sim, K. J. (2022). A mini literature review on current advancements in protein purification techniques. In Biology and Life Sciences Forum,\u00a020, 12. MDPI. https:\/\/doi.org\/10.3390\/IECBM2022-13507","DOI":"10.3390\/IECBM2022-13507"},{"issue":"20","key":"5900_CR60","doi-asserted-by":"publisher","first-page":"2923","DOI":"10.1080\/10826076.2012.743724","volume":"35","author":"P Hong","year":"2012","unstructured":"Hong, P., Koza, S., & Bouvier, E. S. P. (2012). A review size-exclusion chromatography for the analysis of protein biotherapeutics and their aggregates. Journal of Liquid Chromatography & Related Technologies, 35(20), 2923\u20132950. https:\/\/doi.org\/10.1080\/10826076.2012.743724","journal-title":"Journal of Liquid Chromatography & Related Technologies"}],"container-title":["Applied Biochemistry and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12010-026-05900-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12010-026-05900-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12010-026-05900-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T15:15:59Z","timestamp":1792077359000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12010-026-05900-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,1]]},"references-count":60,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["5900"],"URL":"https:\/\/doi.org\/10.1007\/s12010-026-05900-w","relation":{},"ISSN":["0273-2289","1559-0291"],"issn-type":[{"value":"0273-2289","type":"print"},{"value":"1559-0291","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,1]]},"assertion":[{"value":"24 August 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}